Ticker Details
LivaNova PLC Ordinary Shares LivaNova PLC is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.
IPO Date:	October 19, 2015
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$4.53B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.01 | 1.61%
Avg Daily Range (30 D):	$1.20 | 1.55%
Avg Daily Range (90 D):	$1.26 | 1.87%

Institutional Daily Volume
Avg Daily Volume:	.41M
Avg Daily Volume (30 D):	.57M
Avg Daily Volume (90 D):	.62M

Trade Size
Avg Trade Size (Sh.):	64
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	6,946
Avg Institutional Trade:	$2.57M
Avg Institutional Trade (30 D):	$5.73M
Avg Institutional Trade (90 D):	$4.07M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.61M
Avg Closing Trade (30 D):	$12.48M
Avg Closing Trade (90 D):	$9.66M
Avg Closing Volume:	58.35K

News

Jun 27, 2026 @ 8:30 AM Brain Implants Market Size to Reach USD 18.39 Bill... Source: Sns Insider

Apr 23, 2026 @ 5:00 PM Global Perfusion Systems Market to Register Increm... Source: Delveinsight

Mar 27, 2026 @ 2:15 PM MedTech's Edge: How AI and Remote Diagnostics Driv... Source: Equity Insider

Feb 23, 2026 @ 6:00 PM Global Neuromodulation Devices Market Anticipating... Source: Delveinsight

Jan 26, 2026 @ 1:32 AM From Humanoid Robots to AI Seating: VivaNova Debut... Source: Not Specified

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$1.96	$.41	$.56
Diluted EPS	$1.95	$.4	$.56
Revenue	$1.43B	$362.26M	$360.92M
Gross Profit	$967.37M	$243.75M	$239.77M
Net Income / Loss	$107.15M	$22.29M	$30.91M
Operating Income / Loss	$192.24M	$41.47M	$42.58M
Cost of Revenue	$466.09M	$118.51M	$121.15M
Net Cash Flow	$-198.73M	$-95.85M	$-10.53M
PE Ratio